Autonomix Medical, Inc. (AMIX) Stock Analysis & Investment Frameworks
Autonomix Medical, Inc. (AMIX) stock analysis on Invetso. Review Autonomix Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Autonomix Medical, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Autonomix Medical, Inc. Key Financial Metrics
- Market Cap: $825819.00
- Revenue: $N/A
- ROE: -267.73%
- ROIC: -518.15%
- Dividend Yield: N/A
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Autonomix Medical, Inc. Investment Frameworks
Invetso analyzes Autonomix Medical, Inc. (AMIX) across the following frameworks:
- Autonomix Medical, Inc. 10Y Growth Potential
- Autonomix Medical, Inc. Scenario Analysis
- Autonomix Medical, Inc. Risks & Opportunities
- Autonomix Medical, Inc. Economic Moat
- Autonomix Medical, Inc. Business Model
- Autonomix Medical, Inc. Management
- Autonomix Medical, Inc. SWOT Analysis
- Autonomix Medical, Inc. Porter's 5 Forces
- Autonomix Medical, Inc. PESTLE Analysis
- Autonomix Medical, Inc. ESG Analysis